About the Authors
- Michael J Sorich
-
Contributed equally to this work with: Michael J Sorich, Nicolas Pottier
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , Sansom Institute, University of South Australia, Adelaide, Australia
- Nicolas Pottier
-
Contributed equally to this work with: Michael J Sorich, Nicolas Pottier
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , EA2679, Faculté de Médecine de Lille, Pole Recherche, Lille, France
- Deqing Pei
-
Affiliation Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
- Wenjian Yang
-
Affiliation Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
- Leo Kager
-
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , Department of Hematology-Oncology, St. Anna Children's Hospital, Vienna, Austria
- Gabriele Stocco
-
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , Instituto di Ricovero e Cura a Carattere Scientifico, Burlo Garofolo and University of Trieste, Trieste, Italy
- Cheng Cheng
-
Affiliation Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
- John C Panetta
-
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , University of Tennessee, Memphis, Tennessee, United States of America
- Ching-Hon Pui
-
Affiliations University of Tennessee, Memphis, Tennessee, United States of America , Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America
- Mary V Relling
-
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , University of Tennessee, Memphis, Tennessee, United States of America , Pharmacogenetics of Anticancer Agents Research Group, National Institutes of Health Pharmacogenetics Research Network, Memphis, Tennessee, United States of America, and Chicago, Illinois, United States of America
- Meyling H Cheok
-
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , University of Tennessee, Memphis, Tennessee, United States of America
- William E Evans
-
*To whom correspondence should be addressed. E-mail: william.evans@stjude.org
Affiliations Hematological Malignancies Program and the Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America , University of Tennessee, Memphis, Tennessee, United States of America , Pharmacogenetics of Anticancer Agents Research Group, National Institutes of Health Pharmacogenetics Research Network, Memphis, Tennessee, United States of America, and Chicago, Illinois, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
MJS, C-HP, MHC, and WEE designed the experiments and the study. MJS, DP, WY, GS, CC, JCP, MVR, WEE, and MHC analyzed the data. C-HP enrolled and treated patients. NP wrote the first draft of the paper. MJS, WY, LK, GS, CC, C-HP, MVR, MHC, and WEE contributed to writing the paper. MHC collected gene expression and patient data for this study.